118671-03-7 Usage
Description
(2-AMINO-4-METHOXYPHENYL)-ACETONITRILE, with the molecular formula C9H10N2O, is a nitrile derivative of the amino acid tryptophan. It is a chemical compound that serves as a versatile building block in the synthesis of pharmaceuticals and agrochemicals, as well as in the development of organic electronics and materials science.
Uses
Used in Pharmaceutical Industry:
(2-AMINO-4-METHOXYPHENYL)-ACETONITRILE is used as an intermediate in the synthesis of various drugs for the treatment of different diseases and conditions. Its unique properties make it a valuable component in the development of new pharmaceuticals.
Used in Agrochemical Industry:
(2-AMINO-4-METHOXYPHENYL)-ACETONITRILE is used as a building block in the production of agrochemicals, contributing to the development of effective and environmentally friendly solutions for agriculture.
Used in Organic Electronics:
(2-AMINO-4-METHOXYPHENYL)-ACETONITRILE is used as a component in the development of organic electronic materials, such as organic light-emitting diodes (OLEDs) and organic photovoltaics, due to its unique electronic properties.
Used in Materials Science:
(2-AMINO-4-METHOXYPHENYL)-ACETONITRILE is used as a building block in the synthesis of new materials with potential applications in various industries, including aerospace, automotive, and construction, due to its unique structural and chemical properties.
Check Digit Verification of cas no
The CAS Registry Mumber 118671-03-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,8,6,7 and 1 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 118671-03:
(8*1)+(7*1)+(6*8)+(5*6)+(4*7)+(3*1)+(2*0)+(1*3)=127
127 % 10 = 7
So 118671-03-7 is a valid CAS Registry Number.
118671-03-7Relevant articles and documents
ETHER COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS
-
, (2017/03/14)
Compounds, methods of use, and processes for making inhibitors of complement Factor D are provided comprising Formula I, I" and I? or a pharmaceutically acceptable salt or composition thereof. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade. The inhibitors of Factor D described herein reduces the excessive activation of complement.
OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION
-
Page/Page column 18, (2008/06/13)
This invention relates to potent potassium channel blocker compounds of Formula (I) or a formulation thereof for the treatment of glaucoma and other conditions which leads to elevated intraoccular pressure in the eye of a patient. This invention also rela
Synihesis of 3-substituied indoles via a modified madeling reaction
Orlemans,Schreunder,Conti,Verboom,Reinhoudt
, p. 3817 - 3826 (2007/10/02)
Anilides 4a-c,e-k, lla-d in which the amide function is benzylated, or silylated and having different electron-withdrawing groups (EWG) at the methyl methyl in the ortho position of the amide function, cyclize under the influence of potassium tert-butoxide to the corresponding indole derivatives 5a-c,e-k and 9a-d, respectively, under these conditions the chloroacetamides 4d,n and 11e are converted into the tetrahydroquinolines 6a,b and 12, respectively. Treatment of chloroacetamide 4m with KOt-Bu gave, in addition to starting material, indole 5m, tetrahydroquinoline 6c and 2(1H)-quinolinone 7. When 3-indolecarbonitrile 5a is treated with sodium in liquid amnonia debenzylation takes place, while after catalytic hydrogenation with 5% Pd/C the corresponding 2,3-dirnethylindole 8 is formed.